Table 3.
Study | Overall % with nodes at presentation | SCC% with nodes at presentation | Treatment of N0 neck | Overall N0 patients with nodal failure | SCC N0 patients with nodal failure |
---|---|---|---|---|---|
Hinerman 20112! | -- | -- | None | -- | 2/22 (9%) |
-- | -- | ENI unilat ENI bilat |
-- | 1/14 (4%)# 0/9 |
|
Le 20003@ | 11/97 (11.3%) | 9/58 (15.5%) | None | 10/97 (10.3%) | 20% |
-- | -- | ENI | 0/25 (0%) | -- | |
Valentino 20105@ | 2/17 (11.7%) | 1/7 (14.3%) | none | -- | -- |
Paulino 19977! | -- | 4/42 (9.5%) | None | -- | 11/38 (28.9%) |
Homma 20148# | -- | 28/128 (21.9%) | none | -- | 8/83 (9.6%) |
Yagi 20019@ | 9/118 (7.9%) | -- | None | 9/109 (8.3%) | -- |
Cantu 200812@ | 33/399 (8.3%) | 16/156 (10.3%) | None | 51/399 (12.5) | -- |
Kim 199913! | -- | 12/116 (10.3%) | None | 14/104 (13.5%) | 14/104 (13.5%) |
Mirghani 201314$ | 8/155 (5.2%) | None | 16/133 (12.0%) | ||
Jaing 199121@ | 6/73 (8.2%) | -- | none | 11/50 | -- |
-- | -- | ENI | 0/17 | -- | |
Dulguerov 200124@ | 3/103 (2.9%) | -- | none | (4%) | -- |
SEER 1988-199825@ | 45/601 (7.5%) | -- | -- | -- | -- |
Giri 199126@ | 3/41 (7.5%) | -- | -- | 3/35 (8%) | |
Syners 200927$ | 18/168 (11%) | 10/55 (18%) | 11% | 11% |
ENI, elective neck irradiation
SCC of maxillary sinus
includes all malignant histologies originating in the maxillary sinus
T4 SCC lesions of maxillary sinus
includes all histologies and subsites in paranasal sinuses